$24.30
1.566.86%
Last update: Nov 10, 4:00 PM
Tango Therapeutics Inc
TNGXNASDAQ
Tango Therapeutics rose 171.4% from $8.38 to $22.74, ahead of the S&P 500's +9.8%. Its worst day was May 15 (−17.3%), and its low came Nov 12 at $7.67.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Tango Therapeutics closed at its lowest level of the year, 8.5% below where the year started.
−8.5% · S&P 500 +0.1%
Tango Therapeutics shares rose 21.9%, while the S&P 500 fell 0.3%.
+21.9% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
EPS of $-0.29 beat the $-0.32 estimate on $0.00 revenue (est. $500,400.00).
+36.3% · S&P 500 −0.6%
EPS of $-0.32 beat the $-0.32 estimate on $0.00 revenue (est. $578,090.00).
−2.5% · S&P 500 +0.8%
Tango Therapeutics closed at its highest level of the year, 292.6% above where the year started.
+6.3% · S&P 500 +1.8%
EPS of $-0.37 missed the $-0.32 estimate on $0.00 revenue (est. $1.6M).
−4.8% · S&P 500 −0.3%
Tango Therapeutics shares fell 16.4%, while the S&P 500 fell 0.5%.
−16.4% · S&P 500 −0.5%
EPS of $-0.39 missed the $-0.35 estimate on $0.00 revenue.
+5.8% · S&P 500 +2.4%
Where it ended: a close of $22.74 on Nov 9, 2026. Up next: Q4 2026 earnings on Mar 4, 2027 (EPS est. $-0.39).
Nothing in the past 12 months.
All TNGX dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TNGX and SPY from Benzinga historical bars. Not investment advice.
